Lawmakers Require Disclosure of Drug Manufacturers’ Payments to Medical Providers

Lawmakers Require Disclosure of Drug Manufacturers’ Payments to Medical Providers

In an ideal world, doctors and other medical practitioners would be focused solely on patient care.

Their single priority would be patient health and all decisions would be focused on that end.

However, as a New York medical malpractice law firm, we know that all too often financial factors have an undue influence in the medical field.

Of course money influences virtually every part of our lives, from what groceries we buy to where we live.

However, the one area where quality and necessity have to trump financial consideration at all times is in healthcare.

Unfortunately, in too many cases doctors forget this imperative and allow hidden financial influences to affect their work.

Table of Contents

The power of money in the medical field is perhaps most apparent when it comes to the pharmaceutical industry

Most patients rightly trust the recommendations of their doctors when it comes to what medications to take and how much to take.

But are doctors influenced in their recommendations by those in the pharmaceutical industry who stand to gain from increased use of their products?

It is a very real concern.

 

Obama Administration Requires Full Disclosure From Pharmaceutical Companies

The New York Times reported recently on a move by the Obama administration to require pharmaceutical companies to fully disclose monies they’ve paid to doctors including speaking fees, research funds, consulting costs, and money spent on travel and entertainment.

The Times noted that several studies have found such payments do influence the decision-making process and can lead doctors to prescribe medications from the companies who’ve provided financial support.

This includes prescribing risky and inappropriate medicines that can harm patients and also products that carry a high economic cost for the consumer.

When this occurs in our area it is a blatant examples of New York City medical malpractice, and victimized patient have a right to demand accountability.

What Does the New Law Cover?

The new law is tied to Medicare and Medicaid and would cover any medical practice that accepts patients using either program.

There is no distinction based on the nature of the expenditures with the provision requiring reporting of both “proper” and “improper” payments.

Penalties for a violation by the drug companies could run as high as $10,000 per unreported payment and up to $1 million annually.

Liability would extend to pharmaceutical executives who oversee company reporting.

Isn't Marketing New Medications A Necessity?

We applaud this effort to increase transparency involving interactions between pharmaceutical companies and medical practitioners.

Of course some marketing of new medications is necessary.

Like any other business, the pharmaceutical industry needs to be sure that consumers and their medical advisors are aware of new products.

In the case of medication, this often means informing doctors about available products since they serve as gate-keepers to the consumer purchasers.

For this reason, not every expense incurred by a drug company in an effort to reach practitioners is inherently dangerous.

Where We Draw the Line

However, stories abound of lavish expenses designed to sway doctors towards a product even where it may not be the most medically effective treatment.

Some state laws do limit such expenses but the system varies greatly from state to state.

This national bill does not appear to regulate the nature of payments but simply requires transparency.

When health is at issue, openness is always beneficial and requiring disclosure can add an extra layer of accountability.

Closing Thoughts

Medication errors in New York and elsewhere can take many forms including dangerous interactions between medicines and illegible prescriptions resulting in the wrong medicine being dispensed.

Medication errors can also include the prescribing of a medication that is wholly inappropriate or simply not the best option for a given patient.

Depending on the circumstances patients may rightly hold both doctors and pharmaceutical companies responsible for poor medication decision-making.

Patients impacted by a medical error in New York should pursue legal remedies to hold the medical industry responsible for these decisions.

Proper malpractice suits encourage prescribing doctors to truly think through their decisions and prescribe the best treatment for the patient rather than simply prescribing a pill that they heard about at last week’s fancy luncheon.

Join the Discussion

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment

Do You
Have A Case?

Here, at The DiPietro Law Firm, we’re committed to helping victims of sexual abuse and assault find the justice they deserve.

All information discussed during our consultations always remains completely 100% confidential.

Would you like our help?

About Anthony T. DiPietro

Founder Anthony T. DiPietro, Esq. is a compassionate and skilled trial attorney who has completely dedicated the past 23 years of his career to litigating medical malpractice and sexual abuse cases against major corporate institutions including hospitals, medical clinics, schools, and other wrongdoers.

Mr. DiPietro has also obtained some of New York State’s highest verdicts and settlements, and has been selected to New York State Super Lawyers® each year, for the past 10 years in a row.

In 2022, Mr. DiPietro was selected as one of America’s Top 100 High-Stakes Litigators for the landmark cases he’s won on behalf of survivors of sexual exploitation and abuse.

Verdicts & Settlements
Recent Posts
Do You
Have A Case?

Here, at The DiPietro Law Firm, we’re committed to helping victims of sexual abuse and assault find the justice they deserve.

All information discussed during our consultations always remains completely 100% confidential.

Would you like our help?

Related Articles

Cases We're Currently Litigating

Years of Abuse:  1987 – 2016

Brief:  For nearly three decades, Robert Hadden sexually exploited and abused girls and women at Columbia University, under the guise of OB-GYN care.

Read More:  Robert Hadden and Columbia University Sexual Abuse Cases

Years of Abuse:  1961 – 1996

Brief:  22 predator teachers and administrators, over the course of 35 years.

Free Consultation Helpline

If you have any questions about whether or not you have a case, or just want to obtain more information about what you’ve experienced – feel free to contact us through our secure website chat.

You can also contact us by calling us at (212) 233-3600 or toll free at (800) 215-1003.

All of our consultations are free and 100% confidential. Thank you.